Feb 07, 2019

Fagron Launches New Brand Identity and Purpose

Fagron today launched its new brand identity, with its redefined purpose ‘Together we create the future of personalized medicine’. The new brand identity reflects Fagron, our culture, our values, our business segments, while also reflecting our devotion and passion to improve personalized medicine.

Rafael Padilla, CEO of Fagron: “Our purpose reflects our commitment to improve personalized medicine through meaningful innovation. Together, with prescribers, pharmacists and customers, using the innovative power of our growing company and embracing the opportunities personalized medicine has to offer. As a leading player, we aim to lead and take responsibility to further shape and grow the world of personalized medicine. This improves the quality of life and will drive our future growth” 

New logo - Connecting the dots
The new brand identity consists of a powerful logo, a new brand architecture and a brand line. Together, it creates one, distinctive global brand and supports Fagron’s strategic vision to create the future of personalized medicine.

The logo consists of nine dots. Every dot represents an important element of Fagron’s identity. Acknowledging heritage, valuing today and embracing the future. Fagron puts its customer first; the customer is represented by the first red dot. Surrounded by red dots that represent business values deemed to be crucial to deliver on our purpose; speed of execution, entrepreneurship, creativity and quality. Quality is at the center of our new logo, emphasizing that quality is in the middle of our daily operations and main center of reference. The sixth and last red dot stands for the core business being pharmaceutical compounding.

The subsequent three grey dots symbolize the evolution of new business segments that have recently been introduced:
  • Fagron Genomics: Development, production and marketing of innovative genetic tests. The genetic analysis, with algorithm-based software developed by Fagron, takes place in the state-of-the-art Next Generation Sequencing laboratory of Fagron Genomics in Barcelona (Spain).
  • FagronLab: R&D and analytic services for personalized medicine.
  • Fagron Tech: Software and digital technological solutions for personalized medicine.

About Fagron, Inc.
Fagron, Inc., a Fagron global company, is a leading developer and supplier of innovative delivery vehicles (creams, syrups, and lotions), bulk pharmaceutical ingredients, excipients, and high quality compounding equipment. Based in St. Paul, MN, it is a US FDA and DEA-registered pharmaceutical manufacturer that strictly adheres to current Good Manufacturing Practices (cGMP). All batches are tested for identity, strength, quality, purity and compliance with relevant USP or other monographs in Fagron's in-house analytical laboratory. For more information, visit fagron.us.

Market Buzz

Jun 03, 2019 PrimeCare® Integrates MedTek21® to Offer Facility-based Genomic Testing
May 22, 2019 Letco Med Announces the Launch of a New Industry-Leading Website and E-Commerce ...
May 17, 2019 MEDISCA Granted Planetary Mixing Patent and Exclusive Distribution Agreement
May 02, 2019 Transaction Data Systems (TDS) Delivers Smarter Approach to Claim Reconciliation
Apr 22, 2019 Visante healthcare consulting firm announces Judi Jacobi, PharmD, to join consul...
Apr 17, 2019 As an aging population demands more efficient pharmacy solutions, the founder of...
Apr 17, 2019 Adam Wallace Named Chief Technology Officer at Transaction Data Systems (TDS)
Apr 15, 2019 PharmaLink to Exhibit at 2019 Asembia Specialty Pharmacy Summit
Apr 04, 2019 Transaction Data Systems (TDS) Announces Acquisition of Pharm Assess, Inc.
Apr 01, 2019 Chad Collins Named President of Akro-Mils and Jamco Products
Mar 22, 2019 Tutela Welcomes Octapharma Plasma
Mar 18, 2019 Verity Solutions Recognized as Category Leader for 340B Management Systems in 20...
Mar 07, 2019 Stormont Vail Health Partners with Omnicell to Enhance Medication Management Str...
Mar 06, 2019 Rebranding Focuses ALG Mission - Combining Our Best to Bring You Our Best
Mar 04, 2019 RXinsider Celebrates 20 Years, 1999 - 2019
Feb 28, 2019 Lupin launches Generic Ranolazine ER Tablets in U.S.
Feb 18, 2019 QS/1® Offers Compliance Packaging Label Solution
Feb 15, 2019 QS/1 Partnership Offers Compliant Patient Communications
Feb 14, 2019 RXinsider is Proud to Welcome our Newest Partners!
Feb 12, 2019 Albertsons Companies Pharmacies Adopt TemperPack's ClimaCell™ Packaging
Feb 07, 2019 Fagron Launches New Brand Identity and Purpose
Feb 07, 2019 Medicine-On-Time has come together with Clinical Support Services, a leader in M...
Feb 04, 2019 Letco Med and Ananda Professional Partner to Bring CBD and Education to Compound...
Jan 30, 2019 Texas Children’s Hospital Expands Partnership with Omnicell
Jan 16, 2019 Helmer Scientific Launches the First Professional Medical-grade Refrigerators
Jan 15, 2019 The Compliance Team™ celebrates 25 years of accreditation transformation
Jan 11, 2019 CORE Higher Education Group partners with Pharmacists Mutual
Jan 10, 2019 SCA Pharma Awarded National Outsourced I.V. Admixture Services Agreement with Pr...
Jan 08, 2019 Tutela Welcomes the Center for Organ Recovery and Education
Dec 13, 2018 PharmaLink Launches Updated Website

RXinsider Product Overview Videos